Humasis Co Ltd
KOSDAQ:205470
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/B
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Valuation Scenarios
If P/B returns to its 3-Year Average (0.9), the stock would be worth ₩1 469.91 (84% upside from current price).
| Scenario | P/B Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 0.5 | ₩801 |
0%
|
| 3-Year Average | 0.9 | ₩1 469.91 |
+84%
|
| 5-Year Average | 1 | ₩1 736.61 |
+117%
|
| Industry Average | 2.9 | ₩5 027.08 |
+528%
|
| Country Average | 1.1 | ₩1 932.09 |
+141%
|
Forward P/B
Today’s price vs future total equity
Peer Comparison
| Market Cap | P/B | P/E | ||||
|---|---|---|---|---|---|---|
| KR |
H
|
Humasis Co Ltd
KOSDAQ:205470
|
103.6B KRW | 0.5 | -2.8 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
58.8B USD | 0 | 0 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.8T JPY | 9.5 | 39.1 | |
| CH |
|
Alcon AG
SIX:ALC
|
28.9B CHF | 1.7 | 37.3 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
93.1B DKK | 6.7 | 23.1 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
13.5B USD | 3.3 | 33 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.3B GBP | 3.7 | 32.4 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.6B USD | 0.9 | -15.5 | |
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
879B JPY | 5.6 | 49.7 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
37.3B CNY | 4.3 | 22.6 | |
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
8T KRW | 19.1 | -36.2 |
Market Distribution
| Min | 0.1 |
| 30th Percentile | 0.7 |
| Median | 1.1 |
| 70th Percentile | 2.3 |
| Max | 2 461.2 |
Other Multiples
Humasis Co Ltd
Glance View
Humasis Co., Ltd. engages in developing rapid test kits and point-of-care testing instruments. The company is headquartered in Anyang, Gyeonggi-Do. The company went IPO on 2014-12-01. The firm is engaged in the manufacture and sale of immunoquantitative analysis devices, myocardial infarction test equipment, infectious disease detection devices, hormone test devices, cancer marker test devices and other products. In addition, the Company is engaged in the research and development of biomaterials and other products. The firm sells its products within domestic market and to overseas markets. The firm was established in 2000 and is located in Gunpo-si, Gyeonggi-do, South Korea.
